Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

LY-404187

Copy Product Info
😃Good
Catalog No. T7706Cas No. 211311-95-4

LY404187 is a positive allosteric modulator of AMPA receptors

LY-404187

LY-404187

Copy Product Info
😃Good
Purity: 99.34%
Catalog No. T7706Cas No. 211311-95-4
LY404187 is a positive allosteric modulator of AMPA receptors
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$30In StockIn Stock
5 mg$48In StockIn Stock
10 mg$83In StockIn Stock
25 mg$167In StockIn Stock
50 mg$251In StockIn Stock
100 mg$357In StockIn Stock
200 mg$497-In Stock
1 mL x 10 mM (in DMSO)$53In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.34%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

LY-404187 AI Summary
LY-404187 shows potentiation of responses mediated by 100 μM L-glutamate in HEK293 cells expressing human homomeric iGluR4 flip receptors, with an EC50 value of 290.0 nM. It exhibits bioactivity against human GLUR4 and GLUR2 flip and flop receptors, with EC50 values of 420.0 nM, 559.0 nM, 1061.0 nM, and 1905.0 nM, respectively. It acts as an agonist at AMPA and GluR2 receptors and inhibits GluR4, GluR3, GluR1, and GluR2 flop receptors at varying concentrations. The compound has a LogD7.4 of 3.5, indicating a moderate to high distribution coefficient. In viral assays, it inhibits SARS-CoV-2 induced cytotoxicity in Caco-2 cells by 8.75% at 10 μM and in VERO-6 cells by 0.39% at the same concentration, and it inhibits the SARS-CoV-2 3CL-Pro protease by 12.55% at 20 μM. Additionally, LY-404187 shows inhibitory bioactivity on human HDAC6, with 23.94% inhibition in an enzymatic assay with a commercial peptide substrate, but a slight decrease (-2.41%) with a custom peptide substrate. Its effects on cell viability vary across different cell lines, showing both positive and negative growth rate changes depending on the tested cell type..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
LY404187 is a positive allosteric modulator of AMPA receptors
Targets&IC50
GluR2i:0.15 µM (EC50), GluR4i:0.21 µM (EC50), GluR1i:5.65 µM (EC50), GluR3i:1.66 µM (EC50), GluR2o:1.44 µM (EC50)
Chemical Properties
Molecular Weight342.46
FormulaC19H22N2O2S
Cas No.211311-95-4
SmilesCC(C)S(=O)(=O)NCC(C)c1ccc(cc1)-c1ccc(cc1)C#N
Relative Density.1.19 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mg/mL (29.2 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9200 mL14.6002 mL29.2005 mL146.0025 mL
5 mM0.5840 mL2.9200 mL5.8401 mL29.2005 mL
10 mM0.2920 mL1.4600 mL2.9200 mL14.6002 mL
20 mM0.1460 mL0.7300 mL1.4600 mL7.3001 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LY-404187 | purchase LY-404187 | LY-404187 cost | order LY-404187 | LY-404187 chemical structure | LY-404187 formula | LY-404187 molecular weight